👉 Medical researchers are currently investigating the use of CRISPR gene editing technology to treat genetic diseases such as sickle cell anemia and muscular dystrophy, with promising results in early clinical trials. Additionally, studies are ongoing to develop personalized cancer treatments based on individual tumor genetics, aiming to improve patient outcomes by targeting specific mutations driving the disease.
